Cannula Market Size, Share & Industry Analysis, By Product Type (Vascular Access Cannulas, Nasal Cannulas, Cardiovascular & Cardiopulmonary Cannulas, Surgical Cannulas, and Others), By Material Type (Plastic Cannulas, Silicone Cannulas, Metal Cannulas, and Others), By Usage (Disposable and Reusable), By Age Group (Adult and Pediatric), By End-user (Hospitals & ASCs, Specialty Clinics, Homecare Settings, and Others), and Regional Forecast, 2026-2034

The global cannula market size was valued at USD 2.41 billion in 2025. The market is projected to grow from USD 2.55 billion in 2026 to USD 3.93 billion by 2034, exhibiting a CAGR of 5.5% during the forecast period.

A cannula is a thin, flexible tube inserted into the body to administer medication, drain fluids, or deliver oxygen to the patient's body. The market growth is primarily driven by the high volume of hospital admissions, surgical procedures, emergency care, infusion therapy, dialysis, chemotherapy, respiratory support, and cardiac procedures, which is increasing the utilization of cannulas.

BD, Teleflex Incorporated, B. Braun SE, and Medtronic held the highest market share in 2025 due to their well-established presence in key countries and broad product portfolios.

CANNULA MARKET TRENDS

Shift Toward Disposable, Closed-System, and User-Friendly Cannula Platforms to Emerge as a Key Trend

Currently, healthcare providers are increasingly shifting toward disposable, single-use, closed-system, and procedure-ready platforms that reduce infection risk, standardize clinical workflow, and improve staff safety. Also, hospitals are adopting products that minimize blood exposure, accidental disconnection, contamination, and needlestick injury. Moreover, the preference for these cannulas is higher in cardiopulmonary and respiratory care. This is influencing key players to innovate disposable cannulas, enhancing workflow efficiency, safety, comfort, and compatibility with modern hospital protocols.

MARKET DYNAMICS

MARKET DRIVERS

Download Free sample to learn more about this report.

Rising Hospital Procedures and Need for Reliable Vascular Access to Fuel Market Expansion

Over the past few years, there has been an increasing need for reliable vascular access across inpatient, emergency, oncology, critical care, dialysis, and surgical settings. Peripheral IV cannulas and central venous access devices are among the most frequently used invasive devices in hospitals, supporting fluid administration, antibiotics, anesthesia, blood sampling, chemotherapy, parenteral nutrition, and contrast delivery due to an increase in such procedures.

• For instance, according to the Annals of Surgery in April 2024, nearly 1 in 9 U.S. individuals undergoes a surgical procedure annually.

Market growth is further supported by the shift toward patient-safety-focused products, including blood-control IV catheters, closed IV systems, antimicrobial/CHG-impregnated catheters, and ultrasound-compatible insertion systems.

MARKET RESTRAINTS

Risk of Cannula-Associated Complications and Infection to Restrict Market Growth

Cannulas carry risks such as phlebitis, infiltration, occlusion, dislodgement, extravasation, thrombosis, bloodstream infection, needlestick injury, and blood exposure despite their essential role. These risks increase treatment delays, length of stay, product replacement costs, and clinical workload. As a result, hospitals restrict the use of certain cannula types, require strict insertion protocols, or favor higher-priced safety devices, limiting adoption in cost-sensitive healthcare facilities. Moreover, product recalls, sterilization concerns, and user-training requirements are also expected to slow down the penetration of newer devices, hindering the cannula market growth.

• For instance, Edwards Lifesciences recalled certain arterial cannulas after the FDA announced that a 3-4 mm wire section could become exposed, creating a risk of artery puncture, bleeding, and tissue damage.

MARKET OPPORTUNITIES

Growth in Safety-Engineered, Extended-Dwell, and Difficult Vascular Access Solutions to Offer Lucrative Opportunities

In recent years, an aging population, obesity, chronic diseases, oncology therapy, renal disease, ICU care, and repeated hospitalization have increased the number of patients requiring more reliable cannulation.

• For instance, according to the data from the Society of Critical Care Medicine (SCCM) as of June 2026, more than 5.0 million patients are admitted annually to ICUs in the U.S.

In such a scenario, advanced cannula-based solutions such as safety IV cannulas, extended-dwell peripheral cannulas, midline catheters, PICCs, intraosseous access cannulas, and blood-control IV catheters are gaining traction, which is anticipated to create a significant opportunity for key players to develop newer products and expand their distribution network globally.

MARKET CHALLENGES

Pricing Pressure, Training Needs, and Supply Chain Reliability to Challenge Market Expansion

Basic peripheral IV cannulas are commoditized in many markets, creating strong pricing pressure and limiting margins for key players. At the same time, premium cannulas with safety features, antimicrobial properties, pressure-injectable capability, or extended dwell performance must demonstrate clear clinical and economic value to gain procurement approval.

Training is also critical as improper insertion, maintenance, or removal reduces the benefits of advanced devices and increases complications. Moreover, supply chain disruption remains another concern as cannulas are high-volume consumables used daily in hospitals and emergency settings. Such factors together are anticipated to challenge the market expansion in the coming years.

Segmentation Analysis

By Product Type

High Usage of Vascular Access Cannulas in Diverse Applications Fueled Segment Growth

Based on product type, the market is segmented into vascular access cannulas, nasal cannulas, cardiovascular & cardiopulmonary cannulas, surgical cannulas, and others.

The vascular access cannulas segment accounted for the largest global cannula market share in 2025. The segment’s growth is attributed to higher usage of these cannulas in emergency care, surgery, oncology, ICUs, radiology, dialysis, and general wards, which is driving their purchase among hospital procurements.

The nasal cannulas segment is projected to grow at a 6.4% CAGR during the forecast period.

To know how our report can help streamline your business, Speak to Analyst

By Material Type

Plastic Cannulas Led Market Due to Their Flexibility and Cost-Effectiveness

By material type, the market is segmented into plastic cannulas, silicone cannulas, metal cannulas, and others.

The plastic cannulas segment accounted for the largest market share in 2025. The segment’s growth is attributed to its flexibility, patient comfort, cost-effectiveness, disposability, and compatibility with high-volume manufacturing. Moreover, the segment is estimated to hold a 74.1% share in 2026.

The silicone cannulas segment is anticipated to grow at a 6.8% CAGR over the forecast period.

By Usage

Elimination of Need for Reprocessing Boosted Disposable Segment Growth

By usage, the market is segmented into disposable and reusable.

The disposable segment accounted for the largest market share in 2025. Disposable cannulas remove the need for reprocessing, lower the risk of cross-contamination, and deliver reliable performance across procedures, thereby supporting wider adoption and driving segment growth.

The reusable segment is anticipated to grow at a 2.9% CAGR over the forecast period.

By Age Group

Increasing Aging Population and Number of Surgeries Propelled Adult Segment Growth

By age group, the market is classified into adult and pediatric.

The adult segment accounted for the largest market share in 2025. The growth is attributed to the increasing incidence of chronic diseases, surgeries, and hospital admissions in elderly individuals. Furthermore, a surge in the aging population is also anticipated to contribute to the segment’s growth.  

• For instance, according to the data from the World Health Organization (WHO) in February 2025, the global population aged 60 and above is projected to grow from 1.1 billion in 2023 to 1.4 billion by 2030.

The pediatric segment is expected to grow at a 4.8% CAGR during the forecast period.

By End-user

Increasing Diagnostic and Interventional Endoscopic Procedures in Hospitals & ASCs Fostered Segment Growth

On the basis of end-user, the market is segmented into hospitals & ASCs, specialty clinics, homecare settings, and others.

In 2025, hospitals & ASCs dominated the market. Hospitals use large volumes of vascular access cannulas, arterial catheters, nasal cannulas, surgical cannulas, and cardiopulmonary cannulas for routine and complex care. ASCs also contribute to demand through day surgeries, endovascular procedures, anesthesia delivery, and IV medication administration. Moreover, an increasing number of ASCs and hospitals worldwide is expected to support this demand, further driving the segment’s growth. Furthermore, the segment is set to hold a 64.9% share in 2026.

• For instance, as of March 2025, the Ambulatory Surgery Center Association (ASCA) stated that there were 6,500 Medicare-certified ASCs in the U.S.

The specialty clinics segment is projected to grow at a CAGR of 6.1% during the forecast period.

Cannula Market Regional Outlook

Based on geography, the market is classified into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America accounted for the largest share and was valued at USD 0.97 billion in 2024 and USD 1.02 billion in 2025. The region’s growth is attributed to advanced critical care infrastructure, strong adoption of safety-engineered vascular access devices, and the presence of leading manufacturers.

U.S. Cannula Market

In 2026, the U.S. is anticipated to reach USD 0.99 billion, accounting for approximately 38.9% of global revenues.

Europe

Europe is projected to record a 4.8% growth rate during the forecast period, the third-highest globally, reaching USD 0.62 billion in 2026. The region’s growth is supported by established healthcare systems, rising surgical procedures, an increasing geriatric population, and strong demand for vascular access, oxygen delivery, and cardiopulmonary support products.

U.K. Cannula Market

The U.K. market is projected to reach USD 0.11 billion in 2026, representing approximately 4.5% of global revenues.

Germany Cannula Market

Germany's market is expected to reach USD 0.16 billion in 2026, accounting for approximately 6.3% of global revenues.

Asia Pacific

In 2026, the Asia Pacific market is projected to reach approximately USD 0.74 billion, making it the second-largest market globally. The growth is attributed to expanding hospital infrastructure, increasing access to critical care, and growing demand for infusion therapy, oncology treatment, dialysis, and respiratory care.

• For instance, in October 2021, the National Center for Biotechnology Information (NCBI) stated that over the last ten years, China has rolled out multiple investment plans for hospital infrastructure to advance healthcare development.

Japan Cannula Market

Japan is projected to generate approximately USD 0.21 billion in 2026, representing nearly 8.1% of global revenues.

China Cannula Market

China’s market is anticipated to reach around USD 0.30 billion in 2026, accounting for nearly 11.6% of global revenues.

India Cannula Market

India’s market is expected to reach approximately USD 0.10 billion in 2026, accounting for around 3.9% of global revenues.

Latin America and Middle East & Africa

Both Latin America and the Middle East & Africa are anticipated to witness moderate growth. The Latin America market is estimated to reach approximately USD 0.07 billion in 2026. The growth is due to growing private healthcare investment, expanding medical device distribution channels, and increasing demand for emergency care, infusion therapy, dialysis, and respiratory support.

GCC Cannula Market

In 2026, the GCC market is estimated to reach approximately USD 0.02 billion, representing around 0.7% of global revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Broad Product Offerings Combined with Robust Distribution Networks Will Strengthen Market Positions of Leading Companies

In 2025, BD, Teleflex Incorporated, B. Braun SE, and Medtronic held the largest global market share. This share is attributed to their breadth of portfolio, hospital contracts, safety features, infection-control technologies, distribution strength, and procedure-specific innovation. Moreover, other key players are focusing on expanding their market share through expanding their global footprint by strategic partnerships, new facility launches, acquisitions, and collaborations with other firms.

LIST OF KEY CANNULA COMPANIES PROFILED

• BD (U.S.)
• Braun SE (Germany)
• Terumo Medical Corporation (U.S.)
• ICU Medical, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• Vygon (France)
• Polymed (India)
• Romsons Group of Industries (India)
• Medtronic (Ireland)
• LivaNova PLC (U.K.)

KEY INDUSTRY DEVELOPMENTS

• February 2026: Vygon acquired Stiletto and SlipStream technology from Avia Vascular, supporting mid-duration peripheral cannulation.
• April 2025: Vapotherm introduced the Unicorn single-prong nasal cannula, expanding respiratory support interfaces for high-velocity therapy.
• September 2024: Medtronic launched VitalFlow, a new ECMO system, for extracorporeal blood drainage and return.
• September 2024: Braun SE received FDA clearance for the Introcan Safety 2 Deep Access IV Catheter, particularly for difficult vascular access patients.
• May 2024: Teleflex Incorporated launched the Arrow EZ-IO Intraosseous Access Procedure Tray, providing sterile components for IO vascular access.
• November 2023: BD launched next-generation PIVO Pro needle-free blood draw technology compatible with integrated and long peripheral IV catheters.
• June 2023: Teleflex Incorporated launched the Arrow VPS Rhythm DLX Device and NaviCurve Stylet in the U.S. to enhance PICC insertion. This supported the placement of a vascular access cannulation product.

REPORT COVERAGE

The cannula market report offers a comprehensive assessment of the market across all key segments, outlining the major growth drivers, emerging trends, opportunities, restraints, and challenges influencing industry development. It also covers technological advancements, reimbursement scenarios, notable industry developments, market share analysis, and detailed profiles of leading companies operating in the market.

Request for Customization   to gain extensive market insights.

Report Scope & Segmentation